The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

CRISPR Therapeutics › Investing in modestly sized growth stocks can lead to significant returns, but oftentimes it requires taking on a fair bit of risk and being willing to wait at least a few years ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

A newly discovered nuclear role for HSL reveals how imbalances in its location within fat cells may contribute to both ...

Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging[1 ...

A study reveals how RNA modifications regulate the transformation of stem cells into retinal cells. The protein METTL3, which ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...